A coronavirus vaccine candidate has shown signs of promise in older adults during an early stage clinical trial. Using participants aged 56 and older, Moderna’s experimental vaccine produced neutralizing antibodies which are believed to build…
COVID-19 vaccine candidate shows promising results in older patients
